Canada markets closed

Enfusion, Inc. (ENFN)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
9.49-0.13 (-1.35%)
At close: 04:00PM EDT
9.49 -0.01 (-0.11%)
After hours: 04:01PM EDT
Show:
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
181,616
174,535
150,349
111,700
79,565
-
Cost of Revenue
60,513
57,641
47,100
31,845
21,358
-
Gross Profit
121,103
116,894
103,249
79,855
58,207
-
Operating Expenses
Research Development
22,013
19,893
17,163
153,400
6,318
-
Selling General and Administrative
92,934
85,053
98,050
202,339
45,815
-
Total Operating Expenses
114,947
104,946
115,213
355,739
52,133
-
Operating Income or Loss
6,156
11,948
-11,964
-275,884
6,074
-
Interest Expense
-
-
-
4,594
1,662
724
Total Other Income/Expenses Net
-2,106
-2,105
-638
-1,185
82
-
Income Before Tax
5,516
11,484
-12,189
-281,663
4,494
-
Income Tax Expense
1,718
2,231
1,074
579
433
-
Income from Continuing Operations
3,798
9,253
-13,263
-282,242
4,061
-
Net Income
2,541
6,025
-7,654
-158,317
4,061
-
Net Income available to common shareholders
2,621
6,331
-8,608
-187,789
4,061
-
Basic EPS
-0.10
-
-0.10
-2.26
0.06
0.20
Diluted EPS
-0.10
-
-0.10
-2.26
0.06
0.20
Basic Average Shares
85,393
-
85,393
83,045
64,067
64,067
Diluted Average Shares
85,393
-
85,393
83,045
64,067
64,067